Reprogram the Tumor Microenvironment. Overcome Immunotherapy Resistance.

We develop tumor-directed immunotherapies that modulate the tumor microenvironment to enable durable antitumor responses.

OUR SCIENCE

03

Designed for Durable Responses

Aim to convert resistant tumors into responsive disease through local and sustained modulation of the tumor microenvironment.

02

Enable Antitumor Immunity

Create a more permissive immune context to recruit and activate T cells.

01

Target the Tumor Microenvironment

Modulate myeloid, stromal and vascular components that sustain immune resistance.

© 2025. All rights reserved.

All content is for informational purposes only. Modunai Therapeutics’ investigational programs are not approved for clinical use.

Modunai Therapeutics LLC , Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048